Attenuated reovirus displays oncolysis with reduced host toxicity
about
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityPotential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus VariantsGlycan engagement dictates hydrocephalus induction by serotype 1 reovirus.Naturally occurring reoviruses for human cancer therapy.Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis.The sweet spot: defining virus-sialic acid interactions.African Swine Fever Virus NP868R Capping Enzyme Promotes Reovirus Rescue during Reverse Genetics by Promoting Reovirus Protein Expression, Virion Assembly, and RNA Incorporation into Infectious Virions.Reduction of virion-associated σ1 fibers on oncolytic reovirus variants promotes adaptation toward tumorigenic cells.Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike.Viral persistence in colorectal cancer cells infected by Newcastle disease virus.Optimum length and flexibility of reovirus attachment protein σ1 are required for efficient viral infection.NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.A natural reassortant and mutant serotype 3 reovirus from mink in China.Reovirus safety study for proliferation and differentiation of human adipose-derived mesenchymal stem cells.Current understanding of reovirus oncolysis mechanisms.Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
P2860
Q26750568-1EFF65E8-BD60-4505-8174-9F4512A07181Q26775033-59120051-8348-441C-9C36-7D2E7ACAD5BBQ35172332-0A7A2D70-16C8-4270-99B8-9922DBBF5385Q36078485-71C16A11-827D-46CD-9ABB-84F1440AAEF3Q36155535-257475A4-4583-4529-915C-6B44DC44902AQ36685206-A83C7812-4111-4037-8EB2-81C6FBD4E49BQ38712130-D1019EEE-F28D-405C-BDD2-279F7620A07AQ38912745-E33C762F-A016-4F14-AFF6-DC16B27C61B8Q38920004-2C480F3D-ABDA-4C64-8AAA-BF433D4B05D0Q38989363-6CDD9F20-2C36-452D-9A13-30D1CAF9639DQ39312059-F45FC61B-B1E2-479A-9A7F-A268522977B0Q40115977-CC2E66C3-B471-4B7E-97BB-02763BCADBBDQ40316677-D9762E89-322B-4A04-AE3C-A5BCA10BAD34Q40390670-418F2692-D819-4348-87A5-8EDECA900540Q55427397-128D9EBE-89F6-4006-8466-BB15218CAB07Q56986466-1ACBE5DD-1D1B-4939-BF12-9794B88891A6
P2860
Attenuated reovirus displays oncolysis with reduced host toxicity
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Attenuated reovirus displays oncolysis with reduced host toxicity
@ast
Attenuated reovirus displays oncolysis with reduced host toxicity
@en
Attenuated reovirus displays oncolysis with reduced host toxicity
@nl
type
label
Attenuated reovirus displays oncolysis with reduced host toxicity
@ast
Attenuated reovirus displays oncolysis with reduced host toxicity
@en
Attenuated reovirus displays oncolysis with reduced host toxicity
@nl
prefLabel
Attenuated reovirus displays oncolysis with reduced host toxicity
@ast
Attenuated reovirus displays oncolysis with reduced host toxicity
@en
Attenuated reovirus displays oncolysis with reduced host toxicity
@nl
P2093
P2860
P356
P1476
Attenuated reovirus displays oncolysis with reduced host toxicity
@en
P2093
D E Rancourt
K A Garant
N I zur Nieden
P A Forsyth
R N Johnston
S J Urbanski
P2860
P2888
P304
P356
10.1038/SJ.BJC.6606053
P407
P577
2010-12-21T00:00:00Z
P5875
P6179
1041440746